Peptide Synthesis - Company Evaluation Report, 2024

The Peptide Synthesis Market Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Peptide Synthesis Market. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 14 Peptide Synthesis Market Companies were categorized and recognized as quadrant leaders.

The peptide synthesis market is experiencing strong growth, driven by increasing demand for personalized medicine, especially in fields like oncology and autoimmune diseases. Technological advancements in solid-phase and liquid-phase peptide synthesis are improving efficiency and scalability, supporting broader adoption. The market is also expanding due to the growing use of peptides in the nutraceutical and cosmeceutical industries. Key segments include products and services, with products currently dominating the market due to rising investments in peptide-based therapeutics and the adoption of advanced synthesis instruments. The market analysis covers a range of factors including offerings, techniques, applications, end users, and regional trends, highlighting a dynamic and evolving industry landscape.

The peptide synthesis market is driven by the demand for high-purity reagents, technological advancements in instruments, and the rising adoption of peptide-based drugs. Consumables, chemical synthesis methods, and peptide synthesis services are key contributors to market growth, with therapeutic applications leading the way due to increasing use in drug discovery and targeted therapies. Advancements in solid-phase peptide synthesis (SPPS) and the need for custom peptides in various sectors like diagnostics and therapeutics are fueling the market’s expansion.

The 360 Quadrant maps the Peptide Synthesis Market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Peptide Synthesis Market quadrant. The top criteria for product footprint evaluation included Type (Products & Services), By (Consumables, Instruments) By Services (peptide synthesis, peptide purification services, peptide library synthesis, peptide analysis services) By Technique (chemical methods, biological methods) By Applications (therapeutic applications, diagnostic applications, discovery & development applications) By End User (pharmaceutical & biopharmaceutical companies, contract research organizations & contract manufacturing organizations, academic & research institutes, medical device companies, hospitals & diagnostic centers).

Key Players:

The prominent players in the global peptide synthesis market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Kaneka Corporation (Japan), Mesa Labs, Inc. (US), Bachem (Switzerland), Biotage (Sweden), Syngene International Limited (India), CEM Corporation (US), Dalton Pharma Services (Canada), Bio-Synthesis Inc. (US), CSBio (US), ProteoGenix (France), Innovagen AB (Sweden), Biosynth (Switzerland), Aurigene Pharmaceutical Services Ltd. (India), CordenPharma (Switzerland), JPT Peptide Technologies GmbH (Germany), Purolite (US), Biomatik (Canada), CPC Scientific Inc. (US), Advanced ChemTech, Inc. (US), AmbioPharm Inc. (US), Luxembourg Bio Technologies (Israel), AAPPTec (US), AnyGen (South Korea), and ChemPep (US).

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific holds a leading position in the peptide synthesis market. The company’s robust product portfolio, including services, reagents, instruments, and consumables, caters to diverse customer needs globally. Thermo Fisher’s recent developments include launching novel capillary chromatography columns for advanced research laboratories. Through organic developments like product launches and expansions, the company strengthens its market positioning. It also engages in inorganic growth strategies like acquisitions, ensuring a broad market share and positioning itself as a top manufacturer in the sector.

Merck KGaA

Merck KGaA, another key player, focuses on peptide synthesis instruments. With recent expansions, Merck enhances its regional footprint, particularly in emerging markets. Strategic choices, including partnerships and collaborations, are pivotal in reinforcing its position. Merck’s comprehensive product portfolio supports a variety of applications, bolstering its ranking among peptide synthesis vendors.

Agilent Technologies Inc.

Agilent Technologies is recognized for its sophisticated peptide synthesizers and reagents. The company emphasizes innovation in its product offerings and has expanded its presence through both organic and inorganic strategies. Agilent’s commitment to technological advancements and its substantial R&D investments contribute significantly to its competitive edge. These efforts ensure its prominent position in market share and overall ranking.

1 Introduction

1.1 Market Definition
1.2 Stakeholders

2 Executive Summary

3 Market Overview

3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Advancements in Peptide Therapeutics
3.2.1.2 Innovations in Peptide Synthesis Instruments
3.2.1.3 Growing Use of Peptides in Diagnostics and Research
3.2.2 Restraints
3.2.2.1 Regulatory Hurdles
3.2.2.2 High Cost of Peptide Synthesis and Instruments
3.2.3 Opportunities
3.2.3.1 Adoption of Personalized Medicine
3.2.3.2 Strategic Collaborations and Partnerships
3.2.4 Challenges
3.2.4.1 Immunogenicity Issues
3.2.4.2 Environmental Concerns
3.3 Trends/Disruptions Impacting Customer Business
3.4 Supply Chain Analysis
3.5 Value Chain Analysis
3.6 Ecosystem Analysis
3.6.1 Peptide Synthesis Market: Product Manufacturers
3.6.2 Peptide Synthesis Market: Service Providers
3.6.3 Peptide Synthesis Market: End-users
3.6.4 Peptide Synthesis Market: Regulatory Bodies
3.7 Technology Analysis
3.7.1 Key Technologies
3.7.1.1 Solid-Phase Peptide Synthesis (Spps)
3.7.1.2 Liquid-Phase Peptide Synthesis (Lpps)
3.7.1.3 Enzymatic Peptide Synthesis
3.7.1.4 Continuous-Flow Peptide Synthesis
3.7.2 Complementary Technologies
3.7.2.1 Labeling and Tracking Technologies
3.7.2.2 Purification Techniques
3.7.3 Adjacent Technologies
3.7.3.1 Cell-Free Protein Synthesis
3.7.3.2 Protein Design and Engineering
3.8 Patent Analysis
3.9 Key Conferences and Events, 2025-2026
3.10 Porter's Five Forces Analysis
3.10.1 Bargaining Power of Suppliers
3.10.2 Bargaining Power of Buyers
3.10.3 Threat of New Entrants
3.10.4 Threat of Substitutes
3.10.5 Intensity of Competitive Rivalry
3.11 Impact of Ai/Generative Ai on Peptide Synthesis Market
3.11.1 Introduction
3.11.2 Impact of Ai on Peptide Synthesis Ecosystem
3.11.3 Future of Generative Ai in Peptide Synthesis Ecosystem

4 Competitive Landscape

4.1 Overview
4.2 Key Player Strategies/Right to Win, 2021-2025
4.2.1 Overview of Strategies Adopted by Players in Peptide Synthesis Market
4.3 Revenue Analysis, 2019-2023
4.4 Market Share Analysis, 2023
4.5 Company Valuation and Financial Metrics
4.5.1 Company Valuation
4.5.2 Financial Metrics
4.6 Brand/Product Comparison
4.7 Company Evaluation Matrix: Key Players, 2023
4.7.1 Stars
4.7.2 Emerging Leaders
4.7.3 Pervasive Players
4.7.4 Participants
4.7.5 Company Footprint: Key Players, 2023
4.7.5.1 Company Footprint
4.7.5.2 Region Footprint
4.7.5.3 Offering Footprint
4.7.5.4 Technique Footprint
4.7.5.5 Application Footprint
4.8 Company Evaluation Matrix: Startups/Smes, 2023
4.8.1 Progressive Companies
4.8.2 Responsive Companies
4.8.3 Dynamic Companies
4.8.4 Starting Blocks
4.8.5 Competitive Benchmarking: Startups/Smes, 2023
4.8.5.1 Detailed List of Key Startups/Smes
4.8.5.2 Competitive Benchmarking of Startups/Smes
4.9 Competitive Scenario
4.9.1 Product Launches
4.9.2 Deals
4.9.3 Expansions

5 Company Profiles

5.1 Key Players
5.1.1 Thermo Fisher Scientific Inc.
5.1.1.1 Business Overview
5.1.1.2 Products/Services Offered
5.1.1.3 Recent Developments
5.1.1.3.1 Product Launches
5.1.1.4 Analyst's View
5.1.1.4.1 Key Strengths
5.1.1.4.2 Strategic Choices
5.1.1.4.3 Weaknesses and Competitive Threats
5.1.2 Merck KGaA
5.1.2.1 Business Overview
5.1.2.2 Products/Services Offered
5.1.2.3 Analyst's View
5.1.2.3.1 Key Strengths
5.1.2.3.2 Strategic Choices
5.1.2.3.3 Weaknesses and Competitive Threats
5.1.3 Agilent Technologies, Inc.
5.1.3.1 Business Overview
5.1.3.2 Products/Services Offered
5.1.3.3 Analyst's View
5.1.3.3.1 Key Strengths
5.1.3.3.2 Strategic Choices
5.1.3.3.3 Weaknesses and Competitive Threats
5.1.4 Genscript
5.1.4.1 Business Overview
5.1.4.2 Products/Services Offered
5.1.4.3 Recent Developments
5.1.4.3.1 Expansions
5.1.4.4 Analyst's View
5.1.4.4.1 Key Strengths
5.1.4.4.2 Strategic Choices
5.1.4.4.3 Weaknesses and Competitive Threats
5.1.5 Kaneka Corporation
5.1.5.1 Business Overview
5.1.5.2 Products/Services Offered
5.1.5.3 Recent Developments
5.1.5.3.1 Expansions
5.1.5.4 Analyst's View
5.1.5.4.1 Key Strengths
5.1.5.4.2 Strategic Choices
5.1.5.4.3 Weaknesses and Competitive Threats
5.1.6 Bachem
5.1.6.1 Business Overview
5.1.6.2 Products/Services Offered
5.1.6.3 Recent Developments
5.1.6.3.1 Deals
5.1.7 Syngene International Limited
5.1.7.1 Business Overview
5.1.7.2 Products/Services Offered
5.1.8 Mesa Labs, Inc.
5.1.8.1 Business Overview
5.1.8.2 Products/Services Offered
5.1.8.3 Recent Developments
5.1.8.3.1 Product Launches
5.1.8.3.2 Deals
5.1.9 Biotage
5.1.9.1 Business Overview
5.1.9.2 Products/Services Offered
5.1.10 Cem Corporation
5.1.10.1 Business Overview
5.1.10.2 Products/Services Offered
5.1.10.3 Recent Developments
5.1.10.3.1 Product Launches
5.1.10.3.2 Deals
5.1.11 Dalton Pharma Services
5.1.11.1 Business Overview
5.1.11.2 Products/Services Offered
5.1.12 Bio-Synthesis Inc.
5.1.12.1 Business Overview
5.1.12.2 Products/Services Offered
5.1.13 Csbio
5.1.13.1 Business Overview
5.1.13.2 Products/Services Offered
5.1.14 Proteogenix
5.1.14.1 Business Overview
5.1.14.2 Products/Services Offered
5.1.15 Innovagen Ab
5.1.15.1 Business Overview
5.1.15.2 Products/Services Offered
5.1.16 Biosynth
5.1.16.1 Business Overview
5.1.16.2 Products/Services Offered
5.1.16.2.1 Deals
5.2 Other Players
5.2.1 Aurigene Pharmaceutical Services Ltd.
5.2.2 Cordenpharma
5.2.3 Jpt Peptide Technologies
5.2.4 Purolite
5.2.5 Biomatik
5.2.6 Cpc Scientific Inc.
5.2.7 Advanced Chemtech, Inc.
5.2.8 Ambiopharm Inc.
5.2.9 Luxembourg Bio Technologies
5.2.10 Aapptec
5.2.11 Anygen
5.2.12 Chempep
5.2.13 Proteogenix

6 Appendix

6.1 Research Methodology
6.1.1 Research Data
6.1.1.1 Secondary Research
6.1.1.2 Primary Research
6.1.2 Research Assumptions
6.1.3 Research Limitations
6.1.4 Risk Analysis
6.2 Company Evaluation Matrix: Methodology

List of Tables

Table 1 Peptide Synthesis Market: Impact Analysis of Market Dynamics
Table 2 Peptide Synthesis Market: Product Manufacturers
Table 3 Peptide Synthesis Market: Service Providers
Table 4 Peptide Synthesis Market: End-users
Table 5 Peptide Synthesis Market: Regulatory Bodies
Table 6 Peptide Synthesis Market: Innovations and Patent Registrations, 2024
Table 7 Peptide Synthesis Market: Key Conferences and Events, 2025-2026
Table 8 Peptide Synthesis Market: Porter's Five Forces Analysis
Table 9 Overview of Strategies Adopted by Key Players, 2021-2025
Table 10 Peptide Synthesis Market: Degree of Competition
Table 11 Peptide Synthesis Market: Region Footprint
Table 12 Peptide Synthesis Market: Offering Footprint
Table 13 Peptide Synthesis Market: Technique Footprint
Table 14 Peptide Synthesis Market: Application Footprint
Table 15 Peptide Synthesis Market: Detailed List of Key Startups/Smes
Table 16 Peptide Synthesis Market: Competitive Benchmarking Of Startups/Smes
Table 17 Peptide Synthesis Market: Product Launches, January 2021-December 2024
Table 18 Peptide Synthesis Market: Deals, January 2021-December 2024
Table 19 Peptide Synthesis Market: Expansions, January 2021-December 2024
Table 20 Thermo Fisher Scientific Inc.: Company Overview
Table 21 Thermo Fisher Scientific Inc.: Products/Services Offered
Table 22 Thermo Fisher Scientific Inc.: Product Launches, January 2021-December 2024
Table 23 Merck KGaA: Company Overview
Table 24 Merck KGaA: Products/Services Offered
Table 25 Agilent Technologies, Inc.: Company Overview
Table 26 Agilent Technologies, Inc.: Products/Services Offered
Table 27 Genscript: Company Overview
Table 28 Genscript: Products/Services Offered
Table 29 Genscript: Expansions, January 2021-December 2024
Table 30 Kaneka Corporation: Company Overview
Table 31 Kaneka Corporation: Products/Services Offered
Table 32 Kaneka Corporation: Expansions, January 2021-December 2024
Table 33 Bachem: Company Overview
Table 34 Bachem: Products/Services Offered
Table 35 Bachem: Deals, January 2021-December 2024
Table 36 Syngene International Limited: Company Overview
Table 37 Syngene International Limited: Products/Services Offered
Table 38 Mesa Labs, Inc.: Company Overview
Table 39 Mesa Labs, Inc.: Products/Services Offered
Table 40 Mesa Labs, Inc.: Product Launches, January 2021-December 2024
Table 41 Mesa Labs, Inc.: Deals, January 2021-December 2024
Table 42 Biotage: Company Overview
Table 43 Biotage: Products/Services Offered
Table 44 Cem Corporation: Company Overview
Table 45 Cem Corporation: Products/Services Offered
Table 46 Cem Corporation: Product Launches, January 2021-December 2024
Table 47 Cem Corporation: Deals, January 2021-December 2024
Table 48 Dalton Pharma Services: Company Overview
Table 49 Dalton Pharma Services: Products/Services Offered
Table 50 Bio-Synthesis Inc.: Company Overview
Table 51 Bio-Synthesis Inc.: Products/Services Offered
Table 52 Csbio: Company Overview
Table 53 Csbio: Products/Services Offered
Table 54 Proteogenix: Company Overview
Table 55 Proteogenix: Products/Services Offered
Table 56 Innovagen Ab: Company Overview
Table 57 Innovagen Ab: Products/Services Offered
Table 58 Biosynth: Company Overview
Table 59 Biosynth: Products/Services Offered
Table 60 Biosynth: Deals, January 2021-December 2024
Table 61 Aurigene Pharmaceutical Services Ltd.: Company Overview
Table 62 Cordenpharma: Company Overview
Table 63 Jpt Peptide Technologies: Company Overview
Table 64 Purolite: Company Overview
Table 65 Biomatik: Company Overview
Table 66 Cpc Scientific Inc.: Company Overview
Table 67 Advanced Chemtech, Inc.: Company Overview
Table 68 Ambiopharm Inc.: Company Overview
Table 69 Luxembourg Bio Technologies: Company Overview
Table 70 Aapptec: Company Overview
Table 71 Anygen: Company Overview
Table 72 Chempep: Company Overview
Table 73 Proteogenix: Company Overview
Table 74 Peptide Synthesis Market: Risk Analysis

List of Figures

Figure 1 Peptide Synthesis Market, by Offering, 2024 Vs. 2029 (USD Million)
Figure 2 Peptide Synthesis Products Market, by Type, 2024 Vs. 2029 (USD Million)
Figure 3 Peptide Synthesis Market, by Technique, 2024 Vs. 2029 (USD Million)
Figure 4 Peptide Synthesis Services Market, by Type, 2024 Vs. 2029 (USD Million)
Figure 5 Peptide Synthesis Market, by Application, 2024 Vs. 2029 (USD Million)
Figure 6 Peptide Synthesis Products Market, by End-user, 2024 Vs. 2029 (USD Million)
Figure 7 Peptide Synthesis Services Market, by End-user, 2024 Vs. 2029 (USD Million)
Figure 8 Geographical Snapshot of Peptide Synthesis Market, 2024-2029
Figure 9 Peptide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 10 Trends/Disruptions Impacting Customer Business
Figure 11 Peptide Synthesis Market: Supply Chain Analysis
Figure 12 Peptide Synthesis Market: Value Chain Analysis
Figure 13 Peptide Synthesis Market: Ecosystem Analysis
Figure 14 Peptide Synthesis Market: Patent Analysis, 2014-2024
Figure 15 Peptide Synthesis Market: Porter's Five Forces Analysis
Figure 16 Revenue Analysis of Key Players in Peptide Synthesis Market, 2019-2023
Figure 17 Market Share Analysis of Key Players in Peptide Synthesis Market, 2023
Figure 18 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors, 2025
Figure 19 Ev/Ebitda of Key Vendors, 2025
Figure 20 Peptide Synthesis Market: Brand/Product Comparative Analysis
Figure 21 Peptide Synthesis Market: Company Evaluation Matrix (Key Players), 2023
Figure 22 Peptide Synthesis Market: Company Footprint
Figure 23 Peptide Synthesis Market: Company Evaluation Matrix (Startups/Smes), 2023
Figure 24 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 25 Merck KGaA: Company Snapshot (2023)
Figure 26 Agilent Technologies, Inc.: Company Snapshot (2023)
Figure 27 Genscript: Company Snapshot (2023)
Figure 28 Kaneka Corporation: Company Snapshot (2023)
Figure 29 Bachem: Company Snapshot (2023)
Figure 30 Syngene International Limited: Company Snapshot (2023)
Figure 31 Mesa Labs, Inc.: Company Snapshot (2023)
Figure 32 Biotage: Company Snapshot (2023)
Figure 33 Peptide Synthesis Market: Research Design

Companies Mentioned

Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
Genscript
Kaneka Corporation
Bachem
Syngene International Limited
Mesa Labs, Inc.
Biotage
Cem Corporation
Dalton Pharma Services
Bio-Synthesis Inc.
Csbio
Proteogenix
Innovagen Ab
Biosynth
Aurigene Pharmaceutical Services Ltd.
Cordenpharma
Jpt Peptide Technologies
Purolite
Biomatik
Cpc Scientific Inc.
Advanced Chemtech, Inc.
Ambiopharm Inc.
Luxembourg Bio Technologies
Aapptec
Anygen
Chempep
Proteogenix

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2355EUR$2,650USD£2,039GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3776EUR$4,250USD£3,270GBP

Key Players:

Thermo Fisher Scientific Inc.

Merck KGaA

Agilent Technologies Inc.

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-Phase, Solution-Phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

Peptide Synthesis Market Report 2025

Cosmetic Peptide Synthesis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Peptide Synthesis Market Report and Forecast 2024-2032

Peptide Synthesis Market by Product Type (Equipment, Reagents & Consumables, Services), Technology (Hybrid Technology, Liquid Phase Peptide Synthesis, Solid Phase Peptide Synthesis), Application, End-User - Global Forecast 2025-2030